13 Results for "

MELK inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "MELK inhibitor" in MCE Product Catalog:

24
24 Publications Verification
Cat. No.: HY-15512
CAS No.: 1431697-89-0
Purity:  99.70%
Synonyms: OTS167
Target:  

MELK

Research Areas:  

Cancer

OTSSP167 (OTS167) is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.
loading...
    loading...
24
24 Publications Verification
Cat. No.: HY-15512A
CAS No.: 1431698-10-0
Purity:  99.84%
Synonyms: OTS167 hydrochloride
Target:  

MELK

Research Areas:  

Cancer

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100368A
CAS No.: 2096992-20-8
Purity:  99.31%
Synonyms: NVS-MELK8a hydrochloride
Target:  

MELK

Research Areas:  

Cancer

MELK-8a hydrochloride is a novel maternal embryonic leucine zipper kinase (MELK) inhibitor with an IC50 of 2 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100368
CAS No.: 1922153-17-0
Purity:  98.32%
Synonyms: NVS-MELK8a
Research Areas:  

Cancer

MELK-8a (NVS-MELK8a) is a highly potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor with IC50 of 2 nM. MELK-8a also inhibits Flt3 (ITD), Haspin, PDGFRα with IC50s of 0.18, 0.19, and 0.42 μM, respectively. MELK plays an essential role in regulating cell mitosis in a subset of cancer cells .
loading...
    loading...
Cat. No.: HY-101515
CAS No.: 2095596-44-2
Purity:  98.67%
Target:  

MELK

Research Areas:  

Cancer

MELK-IN-1 is a potent inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 and a Ki of 3 nM and 0.39 nM, respectively.
loading...
    loading...
Cat. No.: HY-122665
CAS No.: 2000209-42-5
Purity:  98.64%
Research Areas:  

Cancer

HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be uesd for breast cancer research .
loading...
    loading...
Cat. No.: HY-12420
CAS No.: 1610536-69-0
Purity:  99.68%
Synonyms: MELK-T1 hydrochloride
Target:  

MELK FLT3

Research Areas:  

Cancer

JNJ-47117096 hydrochloride is potent and selective MELK inhibitor, with an IC50 of 23 nM, also effectively inhibits Flt3, with an IC50 of 18 nM.
loading...
    loading...
Cat. No.: HY-122665A
Purity:  98.01%
Research Areas:  

Cancer

HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 TFA also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 TFA can be uesd for breast cancer research .
loading...
    loading...
Cat. No.: HY-12420A
CAS No.: 1610586-62-3
Target:  

MELK FLT3

Research Areas:  

Cancer

JNJ-47117096 is potent and selective MELK inhibitor, with an IC50 of 23 nM, also effectively inhibits Flt3, with an IC50 of 18 nM .
loading...
    loading...
Cat. No.: HY-100368AR
CAS No.: 2096992-20-8
Synonyms: NVS-MELK8a hydrochloride (Standard)
Research Areas:  

Cancer

MELK-8a (hydrochloride) (Standard) is the analytical standard of MELK-8a (hydrochloride) (HY-100368A). This product is intended for research and analytical applications. MELK-8a hydrochloride is a novel maternal embryonic leucine zipper kinase (MELK) inhibitor with an IC50 of 2 nM.
loading...
    loading...
Cat. No.: HY-101515R
CAS No.: 2095596-44-2
Research Areas:  

Cancer

MELK-IN-1 (Standard) is the analytical standard of MELK-IN-1 (HY-101515). This product is intended for research and analytical applications. MELK-IN-1 is a potent inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 and a Ki of 3 nM and 0.39 nM, respectively.
loading...
    loading...
Cat. No.: HY-N17632
CAS No.: 73338-86-0
Moracin G is a plant-derived kinase modulator and receptor ligand that forms stable bindings with multiple key proteins (AKT1, COX2 and Estrogen receptor 1) and competitively inhibits the activity of specific kinases. By binding to MELK to disrupt cell cycle regulation, Moracin G impairs the survival and proliferation of cancer cells, induces cancer cell apoptosis, and thereby exerts anti-tumor potential. Moracin G can be used in research related to periodontitis and breast cancer .
loading...
    loading...
Cat. No.: HY-184447
CAS No.: 3091508-49-2
Target:  

PAK

Research Areas:  

Others

RN193 is a type II kinase inhibitor with a human PAK1 IC50 of 4.28 μM. RN193 functionally inhibits kinase activity of PAK1, PAK2, and PAK3, and engages with their kinase domains in live cells. RN193 induces thermal shifts in CLK1, GSK3B, ULK1, MELK, MAPK13, BRAF, and STK10, indicating binding and stabilization of these proteins. RN193 induces formation of PAK3:PAK2 heterodimers and displaces PAK2 homodimers in live cells. RN193 acts as a tool compound for studying group I PAK conformational states .
loading...
    loading...
  • 1